Drug and Biological Policy Collections
Learn how our new policy collections comprise >3,000 decision points organized into 13 specific areas of D&B logic.
Specialty drugs and biologicals account for almost half of all prescription drug spending—and much of that expense hit a plan’s medical benefits versus drug benefits. New drugs constantly enter the market, and indications and dosing schedules change frequently.
Read our Policy on a Page and learn the benefits and savings our Drug and Biological Policy Collections can deliver to your organization.